JP2012526726A5 - - Google Patents

Download PDF

Info

Publication number
JP2012526726A5
JP2012526726A5 JP2011548484A JP2011548484A JP2012526726A5 JP 2012526726 A5 JP2012526726 A5 JP 2012526726A5 JP 2011548484 A JP2011548484 A JP 2011548484A JP 2011548484 A JP2011548484 A JP 2011548484A JP 2012526726 A5 JP2012526726 A5 JP 2012526726A5
Authority
JP
Japan
Prior art keywords
composition
therapeutic agent
pharmaceutical formulation
present
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011548484A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012526726A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2010/003285 external-priority patent/WO2010131486A1/en
Publication of JP2012526726A publication Critical patent/JP2012526726A/ja
Publication of JP2012526726A5 publication Critical patent/JP2012526726A5/ja
Pending legal-status Critical Current

Links

JP2011548484A 2009-05-15 2010-05-14 薬物動態が改善された鼻腔内用薬学的組成物 Pending JP2012526726A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17890009P 2009-05-15 2009-05-15
US61/178,900 2009-05-15
PCT/JP2010/003285 WO2010131486A1 (en) 2009-05-15 2010-05-14 Intranasal pharmaceutical compositions with improved pharmacokinetics

Publications (2)

Publication Number Publication Date
JP2012526726A JP2012526726A (ja) 2012-11-01
JP2012526726A5 true JP2012526726A5 (https=) 2013-06-27

Family

ID=43084869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011548484A Pending JP2012526726A (ja) 2009-05-15 2010-05-14 薬物動態が改善された鼻腔内用薬学的組成物

Country Status (4)

Country Link
US (1) US9101539B2 (https=)
EP (1) EP2429495A4 (https=)
JP (1) JP2012526726A (https=)
WO (1) WO2010131486A1 (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9701737B2 (en) 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
US20110274701A1 (en) * 2010-05-07 2011-11-10 Camas Incorporated Composition and method for preventing/decreasing respiratory illness
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
CA2519287A1 (en) 2003-03-27 2004-10-14 Bioactis Limited Powder medicine applicator for nasal cavity
WO2006016530A1 (ja) 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
GB0503738D0 (en) * 2005-02-23 2005-03-30 Optinose As Powder delivery devices
CN101668544B (zh) 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
CN101980738A (zh) 2008-02-07 2011-02-23 华盛顿大学 圆周气雾设备
GB2472327B (en) * 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
CN102933230B (zh) * 2010-04-15 2016-03-02 株式会社新日本科学 用于鼻内递送的方法和组合物
CA2828884C (en) 2011-03-03 2021-04-27 Impel Neuropharma, Inc. Nasal drug delivery device
JP6645735B2 (ja) 2011-05-09 2020-02-14 インペル ニューロファーマ インコーポレイテッド 鼻薬送達用ノズル
JP5828007B2 (ja) 2011-12-21 2015-12-02 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 局所投与型の嚥下障害改善用医薬品
AU2013211656B2 (en) * 2012-01-25 2017-07-13 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
CA2908440C (en) * 2012-03-30 2021-04-20 Nuformix Limited Tranilast compositions and cocrystals
US9789071B2 (en) 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
RU2715714C2 (ru) 2013-03-04 2020-03-03 Безен Хелткэа Люксембург Сарл Сухие фармацевтические композиции, включающие наночастицы активного агента, связанные с частицами носителя
US10537692B2 (en) 2013-04-28 2020-01-21 Impel Neuropharma, Inc. Medical unit dose container
HK1218720A1 (zh) 2013-04-30 2017-03-10 欧缇托匹克公司 干粉制剂及使用方法
US9974768B2 (en) 2013-06-13 2018-05-22 Meiji Seika Pharma Co., Ltd. Pharmaceutical for improving dysphagia
JPWO2014199486A1 (ja) * 2013-06-13 2017-02-23 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 嚥下障害改善用医薬品
AU2014315459A1 (en) * 2013-09-03 2016-04-07 G2B Pharma Inc. Intranasal formulation for the treatment of cardiopulmonary resuscitation (CPR), cardiac life support (CLS), anaphylaxis and/or anaphylactoid reactions
EP4008307A1 (en) * 2013-09-24 2022-06-08 Satsuma Pharmaceuticals, Inc. Intranasal dhe formulation for the treatment of headache
US9192570B2 (en) 2013-12-20 2015-11-24 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
WO2016163403A1 (ja) * 2015-04-07 2016-10-13 ニプロ株式会社 経口フィルム製剤
IL257845B (en) 2015-09-10 2022-07-01 Impel Neuropharma Inc In-line nasal delivery device
US11331270B2 (en) 2017-08-20 2022-05-17 Nasus Pharma Ltd. Dry powder compositions for intranasal delivery
US11844859B2 (en) 2017-08-20 2023-12-19 Nasus Pharma Ltd. Dry powder compositions for intranasal delivery
KR102681843B1 (ko) 2017-09-22 2024-07-05 벡추라 인코포레이티드 스테아르산마그네슘을 갖는 건조 분말 조성물
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
WO2019104205A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with dip tube
CN111372635B (zh) 2017-11-21 2022-08-16 英倍尔制药公司 带有入口接口的鼻内装置
AU2018371435B2 (en) 2017-11-27 2023-12-14 Aska Pharmaceutical Co., Ltd. Powder preparation for nasal administration
BR112020013744A8 (pt) 2018-01-05 2022-10-18 Impel Neuropharma Inc Dispensação intranasal de di-hidroergotamina por dispositivo olfativo de precisão
US11278492B2 (en) 2018-01-05 2022-03-22 Impel Neuropharma, Inc. Intranasal delivery of olanzapine by precision olfactory device
WO2019182745A1 (en) 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
WO2019199704A1 (en) 2018-04-09 2019-10-17 Katana Pharmaceuticals, Inc. Oxytocin compositions and methods of use
US11517548B2 (en) 2018-07-19 2022-12-06 Impel Pharmaceuticals Inc. Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
WO2020123607A1 (en) 2018-12-11 2020-06-18 Satsuma Pharmaceuticals, Inc. Compositions, devices, and methods for treating or preventing headaches
CA3125430A1 (en) 2019-01-03 2020-07-09 Impel Neuropharma, Inc. Nasal drug delivery device
MX2021013442A (es) * 2019-05-16 2022-01-06 Shin Nippon Biomedical Laboratories Ltd Formulacion en polvo para administracion intranasal y metodo de fabricacion de la misma.
BR112021023049A8 (pt) 2019-05-17 2022-10-18 Impel Neuropharma Inc Dispositivo de dispensação nasal de uso único
KR20220129586A (ko) * 2020-01-14 2022-09-23 임펠 파마수티컬스 인크. 빈번한 편두통 치료를 위한 디하이드로에르고타민의 반복 투여
US20210283074A1 (en) * 2020-03-16 2021-09-16 Nasus Pharma Ltd. Polymeric Compositions for Intranasal Administration
US12564210B2 (en) 2020-12-16 2026-03-03 Liw Innovation Ab Powder composition
KR20250152464A (ko) * 2024-04-16 2025-10-23 한미약품 주식회사 흡입제 조성물

Family Cites Families (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2224175B1 (https=) 1973-04-04 1978-04-14 Isf Spa
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
JPS5420126A (en) 1977-07-12 1979-02-15 Asahi Chem Ind Co Ltd Pharmaceutical composition
JPS53127553A (en) 1977-04-13 1978-11-07 Asahi Chem Ind Co Ltd Vehicle
AU508480B2 (en) 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
JPS5462328A (en) 1977-10-24 1979-05-19 Asahi Chem Ind Co Ltd Additive for cosmetics
US4226233A (en) 1978-10-10 1980-10-07 Longevity Products, Inc. Respirators
US4300545A (en) 1980-06-23 1981-11-17 Schering Corporation Method and nozzle for nasal vaccination of immature mammals
JPS5934267A (ja) 1982-08-23 1984-02-24 帝人株式会社 粉状薬剤施薬装置
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
DE3345722A1 (de) 1983-12-17 1985-06-27 Boehringer Ingelheim KG, 6507 Ingelheim Inhalator
JPS60224616A (ja) 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
JPS6242888A (ja) 1985-08-21 1987-02-24 カシオ計算機株式会社 太陽電池を備えたｉｃカ−ド
US5731303A (en) 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
JPS63267731A (ja) 1987-04-23 1988-11-04 Asahi Chem Ind Co Ltd 錠剤組成物
JPS6475800A (en) 1987-09-16 1989-03-22 Mitsui Constr Concrete spraying device
ATE99543T1 (de) 1987-10-15 1994-01-15 Syntex Inc Pulverfoermige zubereitungen zur intranasalen verabreichung von polypeptiden.
JPH02196719A (ja) 1989-01-24 1990-08-03 Green Cross Corp:The 粉末状医薬組成物
US4947097A (en) 1989-06-12 1990-08-07 The Grass Valley Group, Inc. Automatic switching of motion control with tactile feedback
DK198591D0 (da) 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5320094A (en) 1992-01-10 1994-06-14 The Johns Hopkins University Method of administering insulin
GB2269992A (en) 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
US5417984A (en) 1992-12-14 1995-05-23 Biocontrol, Inc. Low crystallinity cellulose excipients
US5672581A (en) 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
DE69426415T2 (de) 1993-01-29 2001-07-26 Aradigm Corp., Hayward Intrapulmonares hormonabgabesystem
DE69434304T2 (de) * 1993-03-26 2005-12-29 Merkus, Franciscus Wilhelmus H.M. Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
JPH07165613A (ja) 1993-10-19 1995-06-27 Dot:Kk 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物
SE9303574D0 (sv) 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
WO1995034582A1 (en) 1994-06-16 1995-12-21 Pharmacia S.P.A. Bioadhesive starches and process for their preparation
JPH0898888A (ja) 1994-09-30 1996-04-16 Teijin Ltd 粉末状薬剤噴霧施薬装置
JP3308419B2 (ja) 1995-02-06 2002-07-29 株式会社ユニシアジェックス 鼻腔用投薬器
JP3308425B2 (ja) 1995-03-10 2002-07-29 株式会社ユニシアジェックス 鼻腔用投薬器
JPH08243164A (ja) 1995-03-13 1996-09-24 Unisia Jecs Corp 鼻腔用投薬器
JP3320261B2 (ja) 1995-06-01 2002-09-03 株式会社ユニシアジェックス 吸入式投薬器
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP3317827B2 (ja) 1995-10-09 2002-08-26 株式会社ユニシアジェックス 投薬器
ATE247456T1 (de) 1996-02-27 2003-09-15 Teijin Ltd Puderförmige zusammensetzung zur nasalen anwendung
JP3197221B2 (ja) 1996-02-27 2001-08-13 帝人株式会社 吸収性が改善された粉末状経鼻投与組成物
JP3197223B2 (ja) 1996-02-28 2001-08-13 帝人株式会社 即効性と持続性を兼ね備えた粉末状経鼻投与用組成物
JPH09253208A (ja) 1996-03-21 1997-09-30 Unisia Jecs Corp 鼻腔用投薬器
JPH09276405A (ja) 1996-04-15 1997-10-28 Unisia Jecs Corp 鼻腔用投薬器
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
JP3020141B2 (ja) * 1996-10-07 2000-03-15 株式会社富士薬品 経鼻投与用製剤
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
EP0898978B1 (en) 1997-01-30 2005-03-02 Unisia Jecs Corporation Suction type medicator
CN1169520C (zh) 1997-09-29 2004-10-06 耐科塔医药公司 多孔微粒及其使用方法
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
EP1020193A4 (en) 1997-09-30 2006-05-24 Daiichi Seiyaku Co ORAL PREPARATION
FR2771012B1 (fr) 1997-11-17 2000-03-10 Sofab Pulverisateur nasal
JPH11216357A (ja) 1998-02-03 1999-08-10 Tsutsumi Techno Planning Kk 生理活性物質用の吸着担体
JP3530004B2 (ja) 1998-02-06 2004-05-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
JPH11322582A (ja) 1998-05-06 1999-11-24 Dot:Kk 経鼻吸収用鼻粘膜付着・滞留型キャリヤ
GT199900061A (es) 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
ES2242398T3 (es) 1998-06-05 2005-11-01 Warner-Lambert Company Llc Estabilizacion de composiciones que contienen inhibidores de la enzima de conversion de la angiotensina utilizando oxido de magnesio.
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
AU762145C (en) 1998-08-26 2005-03-17 Teijin Limited Powdery pernasal compositions
WO2000012063A1 (en) 1998-08-26 2000-03-09 Teijin Limited Powdery pernasal compositions
EP1143896B1 (en) * 1998-10-20 2006-12-13 The University of North Carolina at Chapel Hill Methods of hydrating the nasal mucosal surface
GB9828721D0 (en) 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
JP2000229859A (ja) 1999-02-12 2000-08-22 Teijin Ltd 安定なブプレノルフィン経鼻製剤
JP2000239187A (ja) 1999-02-22 2000-09-05 Dotto:Kk 経鼻吸収用組成物
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP3912469B2 (ja) 1999-05-13 2007-05-09 セイコーエプソン株式会社 偽造印刷物判定用インク
JP2001055323A (ja) 1999-08-12 2001-02-27 Teijin Ltd 粉末状経鼻投与用組成物
US6197328B1 (en) 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions
JP4691298B2 (ja) 1999-10-12 2011-06-01 科研製薬株式会社 粉末吸入用製剤及びその製造方法
DE10049392A1 (de) 1999-10-14 2001-04-19 Becton Dickinson Co Flüssigkeits-Ausgabevorrichtung
GB9925934D0 (en) 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
JP2003535042A (ja) 2000-01-20 2003-11-25 バジリア ファルマスーチカ アーゲー 鼻腔に投与可能な環式ペプチド組成物
CA2391740C (en) 2000-06-12 2007-03-13 Teijin Limited Powdered medicine multi-dose administering device
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2002224408B2 (en) * 2000-10-18 2007-08-23 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US6595210B2 (en) 2000-11-27 2003-07-22 Unisia Jecs Corporation Inhalator for administering powder composition
JP2002161030A (ja) * 2000-11-27 2002-06-04 Unisia Jecs Corp 異なる粒径をもった混合粉体の吸入方法
JP2002255795A (ja) 2001-02-26 2002-09-11 Teijin Ltd 経鼻投与用組成物
DE60227660D1 (de) 2001-05-24 2008-08-28 Alexza Pharmaceuticals Inc Freisetzung von antiemetika auf dem inhalationsweg
RU2299743C2 (ru) 2001-07-05 2007-05-27 Транслэйшнл Рисерч Лтд. Композиции инсулина для носового введения
WO2003024396A2 (en) * 2001-09-17 2003-03-27 Glaxo Group Limited Dry powder medicament formulations
AU2002334939A1 (en) * 2001-10-12 2003-04-22 Eugene R. Cooper Compositions having a combination of particles for immediate release and for controlled release
JP3975327B2 (ja) 2001-11-19 2007-09-12 株式会社 バイオアクティス 鼻腔用粉状薬剤施薬装置
US20040092428A1 (en) 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
JP2003175103A (ja) 2001-12-12 2003-06-24 Teijin Ltd 粉末薬剤多回投与器
FR2834212B1 (fr) 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
JP4212019B2 (ja) 2002-01-09 2009-01-21 Ｔｒａｎｓｌａｔｉｏｎａｌ Ｒｅｓｅａｒｃｈ 株式会社 薬物の経鼻投与用組成物
US20050147566A1 (en) 2002-03-12 2005-07-07 Scott Fleming Site specific delivery of co-administered drugs via inhalation
US20030199424A1 (en) 2002-03-20 2003-10-23 Smith Maree Therese Method of treatment and/or prophylaxis
JP3950738B2 (ja) 2002-05-14 2007-08-01 株式会社 バイオアクティス 鼻腔用粉状薬剤施薬装置
WO2004002551A2 (en) * 2002-06-28 2004-01-08 Advanced Inhalation Research, Inc. Inhalable epinephrine
AU2003249105A1 (en) 2002-07-08 2004-01-23 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
GB0215904D0 (en) 2002-07-09 2002-08-21 Team Holdings Uk Ltd Drug delivery system and method
US6855913B2 (en) 2002-08-06 2005-02-15 Hobart Brothers Company Flux-cored wire formulation for welding
CN1176649C (zh) * 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
GB2395900A (en) 2002-12-04 2004-06-09 Elan Drug Delivery Ltd Therapeutic composition for respiratory delivery
GB0228826D0 (en) 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
US20040173211A1 (en) 2003-01-14 2004-09-09 Boehringer Ingelheim International Gmbh Powder inhaler
JP2006516616A (ja) 2003-01-31 2006-07-06 オレクソ・アクチエボラゲット 即効薬剤組成物
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
JP4136724B2 (ja) 2003-03-05 2008-08-20 株式会社日立製作所 鼻腔用投薬器
EP1605858A1 (de) 2003-03-21 2005-12-21 Alfred Schmid AG Gossau Mischkapsel
CA2519287A1 (en) 2003-03-27 2004-10-14 Bioactis Limited Powder medicine applicator for nasal cavity
JP2006527195A (ja) * 2003-06-06 2006-11-30 グラクソ　グループ　リミテッド トリプタンおよびｎｓａｉｄを含む組成物
CA2528064C (en) 2003-06-13 2010-01-12 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
US20050042177A1 (en) 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
AU2003272959A1 (en) 2003-10-09 2005-04-27 Bioactis Limited Powdery medicine dispensing device for nasal cavity
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US8545881B2 (en) * 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
PL2708225T3 (pl) 2004-04-23 2019-07-31 Cydex Pharmaceuticals, Inc. Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
WO2006016530A1 (ja) 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
CN101785892B (zh) 2004-10-06 2014-12-10 贝林格尔·英格海姆国际有限公司 分配装置、存放装置以及分配粉末的方法
MX2007004495A (es) 2004-10-15 2007-05-10 Pfizer Prod Inc Composiciones y procedimientos para la administracion intranasal, bucal, sublingual y pulmonar de vareniclina.
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
JP5694643B2 (ja) 2005-08-05 2015-04-01 スリーエム イノベイティブ プロパティズ カンパニー 改善された流動性を示す組成物
US20070055199A1 (en) 2005-08-10 2007-03-08 Gilbert Scott J Drug delivery device for buccal and aural applications and other areas of the body difficult to access
JP2008518041A (ja) * 2005-08-29 2008-05-29 テバ ファーマシューティカル インダストリーズ リミティド 双峰性粒度分布を有する固体微粒子タダラフィル
EP1815849A1 (en) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
TW200811104A (en) * 2006-04-25 2008-03-01 Theravance Inc Crystalline forms of a dimethylphenyl compound
US7806117B2 (en) 2006-06-07 2010-10-05 Shin Nippon Biomedical Laboratories, Ltd. Peroral powder delivery device
EP2068831A4 (en) * 2006-07-28 2010-07-21 Novadel Pharma Inc ANTIMIGRANEOUS MUNDSPRAY FORMULATIONS AND CORRESPONDING METHODS
US20080029084A1 (en) * 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Device for improved peptide delivery
EA200970258A1 (ru) 2006-09-07 2009-08-28 Пэрион Сайенсиз, Инк. Способ усиления гидратации слизистой оболочки и клиренса слизистой оболочки обработкой блокаторами натриевых каналов и осмолитами
GB0625322D0 (en) 2006-12-19 2007-01-24 Pharmakodex Ltd Pharmaceutical compositions
CN101668544B (zh) * 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
GB2448183A (en) * 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
WO2009049304A1 (en) 2007-10-12 2009-04-16 Map Pharmaceuticals, Inc. Inhalation drug delivery
CA2728808A1 (en) * 2008-02-01 2009-08-06 Vectura Limited Pulmonary formulations of triptans
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator

Similar Documents

Publication Publication Date Title
JP2012526726A5 (https=)
JP7042015B2 (ja) 経口投与型コルチコステロイド組成物
JP6043281B2 (ja) ４−アミノ−５−フルオロ−３−［６−（４−メチルピペラジン−１−イル）−１ｈ−ベンズイミダゾール−２−イル］−１ｈ−キノリン−２−オンラクテート一水和物を含む医薬組成物
EP1945186B1 (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
ES2543108T3 (es) Preparación sólida fácilmente administrable
EP1787640A1 (en) Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
AU2012250862B2 (en) Rapid dissolve tablet compositions for vaginal administration
JPWO2011118453A1 (ja) 固形製剤
WO2010110322A1 (ja) 固形製剤
JP2017523149A (ja) エドキサバンの医薬組成物
WO2009034540A1 (en) Pharmaceutical composition of sevelamer
JPWO2010110320A1 (ja) 固形製剤
CN106999436B (zh) 含有分娩控制物质的口服崩解固体药物剂量单元
JP2013531059A (ja) マルチユニット錠剤組成物
JP2018509473A (ja) ポリマーの水溶液
RU2709526C2 (ru) Фармацевтические композиции, которые содержат лобеглитазон, для перорального введения
CN107106640B (zh) 含有分娩控制物质的口服崩解固体药物剂量单元
JP2014172855A (ja) 口腔内速崩壊性錠剤
CN105596304B (zh) 用于减缓周边血管疾病病患间歇性跛行症状的属喹啉酮衍生物的西洛他唑的新颖调配物
JP2010059152A (ja) モノステアリン酸グリセリンを含有するエナラプリルマレイン酸塩錠剤
JP2016098230A5 (https=)
HK1126394B (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
JP2012012414A (ja) 錠剤、およびその製造方法
AU2014233629A1 (en) Orally administered corticosteroid compositions
HK1235301A1 (en) Pharmaceutical compositions comprising lobeglitazone for oral administration